Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.
Fl.11, Investment Building, No.4009 Shennan Road, Futian Center District, Shenzhen 518048, China
Fang Aihua
Investment Director
Haitao Jin
Chairman
Zhou Songgan
Investment Manager
Lin Yunyu
Investment Director
Past deals in Eastern Asia
Supreium Technology
Series B in 2024
Supreium specializes in the development of computer-aided engineering (CAE) simulation software solutions tailored for intelligent manufacturing. Founded in 2016 and headquartered in Beijing, China, the company offers a software as a service (SaaS) platform that includes various services such as mold design, injection process analysis, and thermal balance assessments. Its offerings also encompass automatic defect detection through image scanning and process consulting services. Serving diverse sectors including medical treatment, marine water conservancy, communications, and industrial markets, Supreium is committed to advancing high-performance digital solutions through its innovative algorithms and cloud-native simulation technologies. The company is recognized for its focus on intelligent industrial design applications and is positioned at the forefront of CAE technology development.
Xvisio Technology
Series B in 2024
Xvisio Technology is a Shanghai-based company that specializes in designing and developing virtual reality and augmented reality products. The firm focuses on visual simultaneous localization and mapping (VSLAM) technologies, providing solutions for spatial perception and interaction in various applications. Its product offerings include the SeerSense sensor hub, which features low latency 6DOF tracking, depth sensing, and AI capabilities for robotics and automated guided vehicle navigation, as well as the SeerLens AR glasses, which are lightweight and equipped with built-in 6DOF tracking. Xvisio Technology serves a range of industries, including robotics, drones, logistics, gaming, manufacturing, and automotive, and has an additional office in Milpitas, California. The company's innovations enable advanced mapping, 3D environmental reconstruction, and object recognition, positioning it as a key player in the XR technology landscape.
Mingdu Zhiyun
Series C in 2024
Mingdu Zhiyun, established in 2017 and located in Hangzhou, China, offers comprehensive contract manufacturing services for pharmaceutical companies. The company specializes in full life cycle solutions that encompass research and development, production, warehousing, and logistics. By leveraging advanced information management systems powered by big data and artificial intelligence, Mingdu Zhiyun enhances the efficiency of the R&D process, enabling drug manufacturers to streamline the development, production, and registration of pharmaceutical products.
Edrive Space
Series B in 2024
Edrive Space specializes in developing advanced aerospace propulsion systems aimed at enhancing the aerospace industry, particularly in China. The company focuses on electrothermal micro-propulsion technologies that address the limitations of traditional electric propulsion systems, such as excessive weight, high power requirements, and low thrust. Their products are designed for the efficient orbiting and networking of micro-nano satellites, making them suitable for applications like emergency collision avoidance of space debris and active deorbiting. Edrive Space's solutions cater to the growing demand for low-cost, standardized, and scalable propulsion systems in the commercial satellite sector, positioning the company as a key player in the evolving landscape of satellite technology.
Unitree Robotics
Series B in 2024
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.
Homerun Smart
Series C in 2023
Shenzhen Qianhai Homerun Technology Co., Ltd. specializes in developing smart pet technology aimed at enhancing the lives of pet owners. Founded in 2015 and headquartered in Guangzhou, China, the company creates innovative products such as smart pet feeders, pet fountains, and smart cat toys. Utilizing artificial intelligence, Homerun Technology focuses on designing solutions that cater to the needs of urban pet owners, particularly those who may have busy lifestyles. The company employs a skilled team of researchers from both domestic and international backgrounds to ensure high-quality development of its products. By integrating smart hardware into daily life, Homerun Technology aims to redefine the pet ownership experience and contribute positively to the pet industry.
Zhongke Tuoda
Series A in 2023
Zhongke Tuoda focuses on addressing fundamental challenges in China's agriculture through innovative physical technology. The company develops fertilizers and pesticides designed to minimize pollution and enhance agricultural environmental protection. By prioritizing the safety of agricultural products, Zhongke Tuoda aims to optimize supply-side structures and reduce the reliance on chemical fertilizers and pesticides that pose risks to both human health and the environment. Their commitment to sustainable agricultural practices reflects an effort to improve the overall safety and quality of agricultural output in China.
Hainayun
Series A in 2022
Hainayun, a prominent entity within the Haier Group, focuses on developing an Internet of Things (IoT) digital city eco-platform in China. The company is dedicated to creating smart communities and smart parks essential for building smart cities. Hainayun aims to establish itself as a leader in this sector by setting industry standards that promote the development of a Digital China. Its offerings include digital infrastructure construction, building life cycle management, and services related to the Artificial Internet of Things (AIoT) and big data operations. Through these initiatives, Hainayun is positioned to facilitate the establishment of advanced digital urban environments.
EPiCMEMS
Venture Round in 2022
EPiCMEMS, a local chip company based in Xiamen, specializes in the development of RF front-end solutions, focusing on 4G+ and 5G RF filters and chips. The company aims to advance the domestic chip industry by producing high-speed, high-quality 5G chips tailored for mobile devices and the Internet of Things (IoT). With operational facilities in Xiamen and Zhangjiang, along with sales and customer support centers in Shenzhen, Xi'an, and Beijing, EPiCMEMS is committed to enhancing connectivity and stability for users across the mobile and IoT sectors.
GAC Aion New Energy Automobile
Series A in 2022
GAC Aion New Energy Automobile is a manufacturer of electric vehicles and offers new energy products and services. It is a Chinese electric vehicle marque of Guangzhou Automobile Corporation. The company was established in 2017 and was introduced in 2018 as a sub-brand and in 2020 as a marque.
MicroPort (Shanghai)
Post in 2022
MicroPort (Shanghai) is a prominent developer, manufacturer, and marketer of advanced medical devices in China, primarily focusing on minimally invasive products for treating vascular diseases. Established in May 1998, the company specializes in a range of cardiovascular and diabetes devices, with its flagship product being a second-generation cobalt-chromium alloy drug-eluting stent. Additionally, MicroPort produces various vascular stent-grafts designed for addressing vascular conditions, as well as innovative stents for applications in the brain and other surgical contexts. The company's products have been utilized in over 1,100 hospitals across China and are exported to more than 20 countries in regions such as Asia Pacific (excluding China), South America, and Europe. MicroPort is committed to enhancing healthcare outcomes through its cutting-edge medical technologies.
Origin Quantum
Series B in 2022
Origin Quantum is a full-stack quantum computing company based in China, established in 2017. The company specializes in the development and application of quantum computing technologies, including quantum chips, measurement and control systems, and quantum software. It offers a quantum computing cloud service platform that facilitates access to quantum computing resources beyond laboratory settings. Origin Quantum is committed to advancing the engineering and industrialization of quantum computing in China, aiming to accelerate its applications across various sectors, including quantum artificial intelligence.
TargetRx
Series B in 2022
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
Tuowei Tianhai
Series A in 2022
TWTH committed to minimizing export costs of logistics in China by establishing the most convenient and efficient Sino-US transport brand. It is dedicated to providing Sino-US ocean freight LCL Door-to-Door service, air freight Door-to-Door service, ocean freight FCL Door-to-Door service, international express service, CNRAM and other international freight services.
Shenzhen MTC Company
Post in 2022
Shenzhen MTC Co., Ltd. is a China-based company established in 2005, headquartered in Shenzhen. It specializes in the design, development, and manufacturing of a diverse range of digital products, including LCD TVs, set-top boxes, LED components, and network communication devices. The company also engages in the production of Internet entertainment products and offers advanced television technologies such as 3D, 4K, and QLED TVs. Additionally, Shenzhen MTC provides residential and commercial lighting solutions, encompassing decorative and functional lightings, as well as outdoor lighting products. Through continuous technological innovation, the company strives to enhance its product offerings and improve its systems.
Unitree Robotics
Series B in 2022
Unitree Robotics, founded in 2016 and based in Hangzhou, China, specializes in the development of innovative robotic solutions for consumer and industrial markets. The company's diverse portfolio features a range of robots, including quadrupeds like Laikago, a four-legged robodog designed as a research platform for scientists and roboticists. Additionally, Unitree Robotics offers humanoid robots and advanced perception systems, catering to various applications across different sectors.
Phylion Battery
Venture Round in 2022
Phylion Battery specializes in the development, production, and sales of lithium-ion batteries with lithium manganate as the positive electrode material. Its annual production capacity is 5GWh, which is a well-known high-tech enterprise of power lithium battery in China. Through 15 years of successful technology transformation, Phylion has provided products and services to 8 million end users and more than 45,000 electric vehicles worldwide, and provided power supply solutions for new energy vehicles around the world. Up to now, with 3GWh annual production capacity, Phylion has provided products and services for 8 million Light EV customers, 45 thousand EV customers, and various industrial projects all over the world.
Regend Therapeutics
Series B in 2022
Regend Therapeutics focuses on the human organ regenerative medicine business and is a global leader in this field. Its core product REGEND001 cell preparation has been accepted by the State Food and Drug Administration and is the world's first autologous stem cell product for respiratory diseases. The company is also the first company in China to be registered by the National Health and Health Commission and the Food and Drug Administration, and is allowed to conduct clinical research on stem cells (Registration No.: CMR-20161214-1002). It is also the first batch of key research and development programs of the Ministry of Science and Technology. And companies that transform research topics. At present, the company has passed ISO9001:2008 quality management system certification, and the stem cell preparation has passed the China Metrology Accreditation (CMA), China Conformity Assessment Committee (CNAS) and IAF International Mutual Recognition. All clinical programs of Jimmy Suisheng are strictly in accordance with the regulations of the National Health Care Commission and the Food and Drug Administration, and are registered with the National Trial Global Database of the National Institutes of Health.
Hozon
Series D in 2022
Zhejiang Hozon New Energy Automobile Co., Ltd., founded in 2014 and headquartered in Tongxiang, China, specializes in the design and manufacture of electric vehicles. The company offers models such as the Nezha U, Nezha N01, and Eureka 02, focusing on the integration of hardware and software to enhance user experience. Hozon emphasizes innovative technology research and development, intelligent manufacturing, and multi-channel sales services to produce cost-effective, high-quality intelligent electric vehicles. With research and development centers in both China and the United States, Hozon aims to advance electricity, intelligence, and connectivity in its offerings, ensuring a simple, intuitive, and comfortable travel experience for its users.
H-CHIP TECH
Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic process R&D and foundry. It is headquartered in Tianjin, China.
Leyue Health
Series B in 2021
Leyue Health, operated by Leyo Information Technology (Shanghai) Co., Ltd., is an innovative platform that integrates internet technology with medical services to streamline the claims process for commercial health insurance. The company has developed an intelligent settlement system that connects medical institutions directly with insurers, allowing for real-time online claims processing. This advancement significantly reduces the traditional claims settlement time, which can take up to 30 days, thereby addressing common challenges such as complicated reimbursement procedures and claims difficulties faced by merchants. In addition to its core services, Leyue Health offers a mobile application for users to manage appointments, make payments, and access test results, alongside providing Wi-Fi services in hospitals. This comprehensive approach aims to enhance the efficiency and accessibility of the healthcare reimbursement process.
Jimuyida
Series B in 2021
Shenzhen Jimuyida Technology Co., Ltd., located in Shenzhen, China, specializes in 3D digital technology, offering a range of products and services that include 3D scanners, engineering modeling services, and home improvement design tools. The company employs advanced technologies such as holography, augmented reality (AR), and virtual reality (VR) to provide customized 3D solutions for various sectors, including retail, design, and real estate. Its software facilitates the creation of detailed, rotatable models, enhancing the visualization and presentation of products for customers. Additionally, Jimuyida has established a research and development center in Wuhan to further innovate in the field of 3D technology.
Harmony Cloud
Series C in 2021
Harmony Cloud, operating as Hangzhou HarmonyCloud Technology Co., Ltd., is a cloud computing startup focused on enhancing IT support for traditional enterprises. The company offers an enterprise Container as a Service (CaaS) platform designed for efficient hybrid cloud management, leveraging the Kubernetes framework. Its platform incorporates advanced technologies such as elastic computing, distributed deployment storage, and software-defined networking, along with robust security features like mirror-level security scanning. Additionally, it provides a user-friendly graphical interface for cloud operations and maintenance, enabling customers to manage resources and applications more effectively. This comprehensive approach aims to accelerate application delivery and improve operational efficiency for businesses in the Chinese market.
EQ Consulting
Seed Round in 2021
EQ Consulting is a financial software solution provider that specializes in consulting services and comprehensive solutions for valuation, risk control, and quantitative analysis. The firm primarily serves large and medium-sized financial institutions, including over ten major banks and financial entities in Hong Kong and Singapore. EQ Consulting's core offerings encompass business consulting, product development, project implementation, and system solutions. Additionally, the company provides customized financial product quantitative modeling, front-end trading, risk control, and back-office solutions. Recent funding has been allocated to enhance product development, research new computing technologies, expand business operations, and build overseas quantitative analysis teams.
Beijing Sudo Technology
Series A in 2021
Beijing Sudo Technology provides privacy protection technical services from the perspective of systematic comprehensive engineering.
Leads Biolabs
Series C in 2021
Leads Biolabs is a biotechnology company focused on developing innovative antibody-based therapeutics to address unmet medical needs in oncology and immunological diseases. Founded in 2014 and headquartered in China, the company has established a strong research and development pipeline featuring over ten projects centered on monoclonal and bispecific antibodies for cancer immunotherapy. By concentrating on tumor immunotherapy, Leads Biolabs aims to enhance treatment outcomes and access for patients globally, thereby improving their medical conditions and overall quality of life.
Jiepei.com
Series B in 2021
Jiepei.com Inc. is an online marketplace based in Hangzhou, China, specializing in the manufacturing of printed circuit boards (PCBs) and related electronic components. The company operates Jieji Extreme Speed PCB Super Factory, which aims to create a collaborative platform for the electronic information industry. Jiepei.com focuses on various sectors including consumer electronics, communications equipment, industrial control, instrumentation, intelligent hardware, and the Internet of Things. It offers professional one-stop services such as PCB customization, surface mount technology (SMT), and component distribution, catering to manufacturers in the electronics field.
IPLUSMOBOT
Series B in 2021
IPLUSMOBOT is one of the global leading companies in the autonomous mobile robot field, ranking the first of China industrial logistics natural navigation AMR market occupancy. IPLUSMOBOT was founded in 2016, whose headquarter is in Hangzhou and its subcompany have been established in Shenzhen and Tokyo. It provides logistics automatic, digital and intelligentized products to manufacturing industry, and helps enterprises increase the configuration efficiency of production and circulation resources, and integrated operation efficiency and benefits. So far, IPLUSMOBOT has served over 1000 customers, and the business scenes cover such industries as semiconductor, FPD, electronics, Lithium battery, photovoltaic, automobile, aviation, household electrical appliances, pharmaceutical, energy, food industry and so on.
Yunphant Blockchain
Series B in 2021
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Longcheer
Series B in 2021
Longcheer is a company based in Shanghai, China, that specializes in providing design and research solutions for mobile telecommunications devices. It focuses on the development, manufacturing, and servicing of various terminals, including smartphones, tablets, AI PCs, and automotive electronics. In addition to its core activities, Longcheer also offers hardware, software, system testing, and exterior design services. The company is involved in the manufacturing and trading of mobile handsets, printed circuit boards, and related data products. Furthermore, Longcheer engages in property investment activities, diversifying its business portfolio. Founded in 2002, the company has established itself as a key player in the telecommunications sector.
Cryofocus Biotech
Series B in 2021
Cryofocus Biotech is a Shanghai-based cryoablation device manufacturer, focusing on the application of cryogenic technology in the field of cardiovascular interventional therapy.
Sino Vision
Series D in 2020
Sino Vision is a medical device manufacturing company based in China. The company provides X-ray computed tomography equipment, sROBOT robot CT navigation system, and sAI intelligent imaging solutions. Sino Vision was established in 2012.
Htrip
Series A in 2020
Htrip is a Tourism company that specializes in providing hotel's Internet communication platform. The company is committed to upgrading interactive TV, wifi and IoT hardware in hotel rooms by self-investment hardware or hotel joint investment, and combining it with the hotel's original PMS management system. Htrip was founded in 2016 and headquartered in Guangdong, China.
UnionTech
Series A in 2020
UnionTech is a Chinese software company established in 2019, headquartered in Beijing. It specializes in developing and providing basic software solutions, particularly focused on operating systems. The company aims to create a robust innovation ecosystem for Chinese operating systems, offering products that are safe, stable, intelligent, and user-friendly for various industries. UnionTech's primary product is the Unity Operating System, which is compatible with Linux and designed to enhance operational efficiency for users. To support its initiatives, UnionTech has established local technical support institutions, research and development centers, and software and hardware adaptation centers in several major cities, including Wuhan, Shanghai, Guangzhou, and Nanjing.
FJ Dynamics
Venture Round in 2020
FJ Dynamics is a global robotics company founded in 2017 and headquartered in China. The company specializes in developing digital and autonomous solutions for various sectors, with a strong focus on agriculture and construction. FJ Dynamics integrates advanced technologies such as big data, the Internet of Things, deep learning, unmanned driving, and machine vision to create intelligent logistics robots and innovative agricultural machinery. Their product offerings include intelligent ground robots, terminal unmanned logistics systems, agricultural robots, and high-speed rice transplanters. By enhancing productivity and efficiency in the agricultural industry, FJ Dynamics aims to transform traditional practices through automation and smart technology.
Chasing Innovation
Series A in 2020
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones. With additional offices in Beijing, Kunming, and Chengdu, the company was founded by a team of divers and technology enthusiasts with experience from notable firms. Its flagship product, the Gladius, is designed for underwater exploration and is capable of diving up to 100 meters while offering a horizontal range of 500 meters. The drone can operate underwater for up to three hours, capturing high-quality images and videos in Ultra HD, which can be stored internally or live-streamed in real-time. The Gladius serves a variety of applications, including diving, fishing, island exploration, search and rescue operations, and aquaculture monitoring, making it a versatile tool for both recreational and professional use.
LP Pharmaceuticals
Series C in 2020
LP Pharmaceuticals (Xiamen) Co., Ltd., located in Xiamen Biomedical Industry Base which formulates and manufactures pharmaceuticals with enhanced delivery properties. The company was founded in 2012 by a group of scientists and business professionals with extensive experience in the US and Chinese pharmaceutical industry. Proprietary delivery platforms include mucosal and oral controlled release. Therapeutic areas currently concern central nervous system, digestive system, cardiovascular, cancer and AIDS.
Wenge Group
Series C in 2020
Zhongke Wenge is positioned in the wisdom media big data application, aiming to provide technology engine for China's media transformation and upgrading, and to serve media communication capacity building. The company is facing the influence of China's media, government and enterprises, and is committed to the research and development of new media big data technology and systems. It has formed the "Wenhai" new media big data platform, "Wen Ge" central kitchen, "Wen Si" decision-making service. The platform's three major product systems, as well as the “Wenhai” new media data service platform, the “cloud trace” communication monitoring and evaluation system, the “Yunyong” media visualization analysis system, the “Yayi” text semantic analysis component, and the four flagship products.
Shanghai Horizon Medical Technology
Venture Round in 2020
Shanghai Horizon Medical Technology focuses on medical solutions its business covers the R&D, manufacturing, marketing, and technical support of products at every step of the ART treatment process, including egg and sperm collection, fertilization, embryo culture, cryopreservation, and embryo transfer. It was founded in 2018 and headquartered in Shanghai, China.
TargetRx
Series A in 2020
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
QureBio
Series A in 2020
QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug development including phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform. The company was founded in 2017 and is based in Pudong District, Shanghai.
Encootech
Series B in 2020
Established in July 2017, Shanghai Yunsheng Information Technology Co., Ltd. is the first high-tech company in China to focus on the development of intelligent RPA software robot platform. Headquartered in Jing'an District, Shanghai, it has a research and development center in Suzhou. In 2019, a subsidiary was opened in Tokyo to arrange the Japanese market. The core team of the company, led by technical experts from Microsoft's cloud computing department, independently developed the first intelligent RPA robot platform in China, Digi4th. Yunsheng Technology focuses on providing intelligent software robot products and solutions for the Internet, finance, energy, telecommunications, manufacturing and other industries. It can enhance the efficiency of traditional industry operations and accelerate digital transformation through RPA empowerment.
GenFleet Therapeutics
Series B in 2020
GenFleet Therapeutics is a developer and researcher of molecular pharmaceuticals targeting cancer treatments. The company specializes in developing innovative molecular-level pharmaceuticals and antibody drugs targeting various cancer systems, providing effective medical solutions to reactivate tumor-specific immune responses and to mobilize the body's own immune system.
Maijing Gene
Series B in 2020
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
RemeGen
Private Equity Round in 2019
RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, specializing in the research, development, manufacture, and commercialization of novel biologics, particularly monoclonal antibodies and antibody-drug conjugates. The company focuses on addressing unmet medical needs for patients with life-threatening conditions, offering products such as Telitacicept for systemic lupus erythematosus and Disitamab Vedotin for various cancers. RemeGen's innovative therapies target major diseases, including autoimmune disorders, oncology, and ophthalmology. With additional laboratories and offices in Beijing and California, RemeGen primarily operates in China while also maintaining a presence in the United States, where it derives a significant portion of its revenue.
EigenCOMM
Venture Round in 2019
EigenCOMM Ltd. is a Shanghai-based company established in 2017, specializing in the research, development, and sales of cellular network internet chips. The firm focuses on providing complete solutions for Internet of Things (IoT) ecosystems, particularly in the realm of smart home appliances. EigenCOMM's product line includes standard NB-IoT terminal chips, which ensure comprehensive coverage of cellular data connections and extended standby times, positioning the company as a key player in the IoT market.
Akeso Biopharma
Series D in 2019
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
Golden Technology
Series B in 2019
Golden Technology is a big data service company based in China that specializes in electronic invoicing solutions powered by blockchain technology. The company has developed a digital invoicing and transaction record-keeping platform that serves various sectors, including grocery retailers, parking lots, and restaurants. This platform offers a range of services, including electronic invoicing, reimbursement processing, record-keeping, and transaction management. By utilizing this technology, Golden Technology provides convenient and cost-effective alternatives to traditional paper-based receipts, streamlining financial processes for businesses and enhancing efficiency in transaction management.
Hrain Biotechnology
Series B in 2019
Hrain Biotechnology is a tumor immunotherapy technology developer, using the tumor immunotherapy technology CAR-T to provide cancer patients with precise treatment based on biological and cellular technology, and built centers in Beijing, Jiangsu, Chongqing, Henan and other places. Clinical trial platform.
Mino Space
Series A in 2019
Mino Space is a private commercial satellite company that integrates satellite development and satellite applications. The company is mainly engaged in R&D and manufacturing services of micro-nano satellite systems, independently researching and developing micro-nano satellite platform and core components, possessing satellite star design and integration testing capabilities, and has experience in developing satellite systems such as electronic communication and optical payloads. The ability to coordinate and coordinate the overall situation. The company independently develops satellite terrestrial communication terminals and has experience in satellite communication system integration. It can provide satellite resources-based integrated information system solutions for defense, industry, and regional users. Founded in 2017, Beijing Weina Star Technology Co., Ltd. is located in Yongfeng Industrial Base, Zhongguancun, Beijing.
ArchForce Technology
Series B in 2019
ArchForce Technology is a provider of business solutions tailored for the securities and asset management sectors. The company develops advanced distributed management systems that include real-time risk management platforms, trading systems, and market data solutions. Their offerings support financial institutions such as securities firms, funds, banks, and insurance companies by facilitating transactions, clearing processes, and investment management. ArchForce Technology aims to enhance operational efficiency and risk control within China's financial infrastructure, delivering comprehensive support to its clients in navigating complex market conditions.
Anlogic
Series D in 2019
Shanghai Anlogic Infotech Co., Ltd., founded in 2011 and located in Zhangjiang Hi-Tech Park, Pudong New Area, focuses on the research, development, design, and sales of programmable logic devices. The company specializes in providing cost-effective field programmable gate arrays (FPGAs), programmable system-on-chips, custom embedded eFPGA intellectual property, and related software design tools. Anlogic aims to deliver innovative system solutions tailored to meet the diverse needs of its customers in various industries.
KK Group
Series C in 2019
KK Group operates an online-to-offline marketplace in China that focuses on imported products. The company sources a diverse range of items, including snacks, personal care products, makeup, home furnishings, and stationery, from renowned international brands. Through its platform, KK Group allows consumers to purchase these products from physical stores around the world using their mobile devices, bridging the gap between online shopping and offline retail. This approach provides users with direct access to premium imported consumer goods, enhancing their shopping experience.
MabPlex
Series A in 2019
MabPlex International Ltd is a contract development and manufacturing organization specializing in biopharmaceuticals, including monoclonal antibodies, recombinant proteins, antibody-drug conjugates, and bispecifics. Founded in 2013 and headquartered in Yantai, China, with an additional office in Fremont, California, MabPlex provides a range of services from drug development to manufacturing. The company offers customized mammalian cell media, cell banking, and active pharmaceutical ingredient manufacturing, as well as biologics and ADC fill and finish services. MabPlex aims to deliver high-quality solutions for biomanufacturing, catering to partners globally.
Vhall
Series D in 2018
Vhall is an online activity marketing and commercial platform based in China that specializes in virtual meetings and live broadcasting services. Affiliated with Beijing Vhall Time Science and Technology Co., Ltd., Vhall aims to deliver a world-class online marketing experience for Chinese enterprises. The platform provides an interactive environment where users can engage in 3D virtual reality meetings, participate in live seminars, and view product demonstrations. Vhall's services facilitate remote communication for enterprises, enhancing work efficiency and saving time by enabling seamless interactions without the need for in-person meetings.
Databaker
Series A in 2018
Databaker, Inc. is an AI company based in Beijing, China, founded in 2016, that specializes in intelligent voice interaction and comprehensive data services. The company offers a range of solutions, including voice synthesis, voice recognition, and image data annotation, as well as text-to-speech services. By leveraging its open AI+SaaS platform, Databaker provides clients with advanced technical capabilities in voice interaction and various forms of data acquisition, such as natural language processing. This enables enterprises to select appropriate voice interaction products tailored to their specific applications, effectively enhancing their operational efficiency and user engagement.
Yunphant Blockchain
Series A in 2018
Yunphant Blockchain is a China-based company that specializes in designing and developing blockchain platforms. Founded in 2014, it offers a range of services and products aimed at enhancing the financial industry. The company's backend as a service (BaaS) platform supports applications such as equity and bond trading, notary certification, data security, and supply chain finance. Its offerings include a Blockchain service platform and a Blockchain monitor platform, which provide real-time monitoring of node performance, block generation times, and system exceptions. Additionally, Yunphant Blockchain features a hierarchy ledger, segregated business logic, consortium blockchain capabilities, a YBFT consensus algorithm, and various encryption methods. The company's focus on performance, security, privacy, and scalability allows clients to effectively utilize blockchain technology across multiple sectors.
Akeso Biopharma
Series C in 2018
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
Teligene
Series C in 2018
Teligene Ltd. is a pharmaceutical research and development company based in Jiangsu, China, established in 2011. The company specializes in the development of small-molecule drugs, particularly innovative treatments for oncology. Teligene's focus is on the research, development, and industrialization of small molecule targeted anti-tumor drugs, utilizing advanced drug development technologies. The experienced management team is well-versed in contemporary trends and practices in drug development both domestically and internationally. Teligene aims to create original anti-tumor drugs with independent intellectual property rights, addressing emerging areas of research and development in the pharmaceutical field.
Shenzhen Raybow Optoelectronics
Series A in 2018
Shenzhen Raybow Opto is a high-power semiconductor laser manufacturer located in Shenzhen, China and founded by Research Institute of Tsinghua University in Shenzhen and some of the leading experts in the semiconductor laser industry. Shenzhen Raybow Opto’s core competency includes device design and simulation, a fully functional semiconductor laser chip fabrication line and a packaging and testing facility. The semiconductor laser products offered by Shenzhen Raybow Opto are among the highest power and the most reliable laser diodes available in the market. Shenzhen Raybow Opto also provides the customers with the state-of-the-art testing equipment, services of design consulting, characterization and failure mode analysis.
TargetRx
Seed Round in 2018
Shenzhen TargetRx, Inc. is a pharmaceutical research and development company based in Shenzhen, China, established in 2014. As a Sino-American joint venture, it focuses on the creation of innovative anti-tumor drugs, specializing in third-generation small molecule targeted therapies for cancer patients. The company is dedicated to addressing challenges such as acquired drug resistance in cancer treatment. Under the leadership of Dr. Yihan Wang, a prominent medical expert with extensive experience in small molecule targeted therapies, Shenzhen TargetRx aims to position itself as a leading platform for targeted drug development. The company engages in the design, screening, evaluation, optimization, and research of original anti-tumor drug candidates, holding independent intellectual property rights to its innovations. With a commitment to improving cancer treatment outcomes, Shenzhen TargetRx strives to transform cancer from a leading cause of mortality into a manageable chronic condition.
HaploX
Series B in 2018
HaploX Biotechnology Co., LTD., founded in 2014 and based in Shenzhen, China, focuses on developing genomic solutions for personalized medicine, particularly in cancer patient management. The company integrates advanced technologies such as liquid biopsy, gene sequencing, artificial intelligence, and big data to enhance cancer diagnostics. HaploX specializes in extracting and amplifying ultra-low concentrations of DNA from liquid samples, enabling precise detection of circulating tumor DNA. Its innovative tools facilitate tagged sequencing and streamline data management and analysis, aiming to improve the accuracy and effectiveness of cancer detection and treatment strategies.
Chasing Innovation
Seed Round in 2018
Chasing Innovation Technology, established in 2016 and headquartered in Shenzhen, China, specializes in the development and manufacturing of submersible drones. With additional offices in Beijing, Kunming, and Chengdu, the company was founded by a team of divers and technology enthusiasts with experience from notable firms. Its flagship product, the Gladius, is designed for underwater exploration and is capable of diving up to 100 meters while offering a horizontal range of 500 meters. The drone can operate underwater for up to three hours, capturing high-quality images and videos in Ultra HD, which can be stored internally or live-streamed in real-time. The Gladius serves a variety of applications, including diving, fishing, island exploration, search and rescue operations, and aquaculture monitoring, making it a versatile tool for both recreational and professional use.
ArchForce Technology
Venture Round in 2018
ArchForce Technology is a provider of business solutions tailored for the securities and asset management sectors. The company develops advanced distributed management systems that include real-time risk management platforms, trading systems, and market data solutions. Their offerings support financial institutions such as securities firms, funds, banks, and insurance companies by facilitating transactions, clearing processes, and investment management. ArchForce Technology aims to enhance operational efficiency and risk control within China's financial infrastructure, delivering comprehensive support to its clients in navigating complex market conditions.
Uoko.com
Series C in 2018
Uoko.com, operated by Sichuan UOKO Investment Management Co. Ltd., is an online property leasing platform based in Chengdu, China, founded in 2012. The platform specializes in apartment rental services, targeting young students and professionals in second-tier cities like Chengdu and Wuhan. Uoko.com offers standardized long-term rental apartments while also providing comprehensive property management solutions for homeowners. These services include post-rental offerings such as cleaning, maintenance, and renovation, enabling homeowners to effectively monetize their vacant properties. By focusing on high-quality rental options and community-oriented after-sales services, Uoko.com aims to meet the needs of urban rental groups and enhance the overall rental experience.
Maijing Gene
Series A in 2018
Maijing Gene is a gene detection technology company that specializes in R&D, production, and sales of molecular diagnostic products. It is also committed to promoting the application of second-generation high-throughput sequencing technology in the field of precision medicine. Maijing Gene was established in 2015 and is based in Guangzhou, China.
XTX Technology
Series A in 2018
XTX Technology Limited is a semiconductor company based in Shenzhen, China, specializing in high-reliability and cost-effective memory products. The company manufactures a variety of flash memory solutions, including NAND MCP, NOR MCP, SD NAND, SPI NAND, SPI NOR Flash, and eMMC, which are designed for embedded applications across multiple sectors such as mobile devices, automotive equipment, security systems, point-of-sale terminals, home appliances, and Internet of Things devices. In addition to its memory products, XTX Technology offers SIP assembly services aimed at optimizing customer bill of materials costs and enhancing production efficiency, while also improving software intellectual property security. The company’s innovative technology supports a wide range of applications, contributing to advancements in consumer electronics, network communications, and industrial and medical fields.
Zelgen
Series B in 2018
Zelgen is a biopharmaceutical company based in Suzhou, China, dedicated to the research, development, manufacturing, and sales of innovative medications. The company focuses on creating new chemical and biological drugs for a range of therapeutic areas, including cancer, hematologic diseases, and hepatobiliary conditions. Zelgen aims to address unmet medical needs within the domestic market by providing high-quality, safe, effective, and affordable treatment options. Through its commitment to innovation and R&D, Zelgen aspires to establish itself as a leading player in the Chinese biopharmaceutical sector.
Huada Empyrean Software
Corporate Round in 2018
Founded in June of 2009 by China Integrated Circuit Design Group and SDIC High-tech Investment, the headquarters of Empyrean is located in Beijing, China’s Wang Jing Hi-Tech Park. Huada Empyrean Software provides the professional electronic design automation (EDA) software, IP, and design services, including analog / mixed analog-digital IC design of the whole process solutions, digital SoC design optimization solutions, Flat Panel Design (FPD) optimization solutions and customized consulting services. Thanks to the nearly 30 years of accumulation in terms of technology, products, team, and market, Empyrean boasts with the largest and leading-edge research and development team and is also China's largest EDA software supplier. As the relying institution of the National IC CAD Engineering Research Center, Empyrean has adhered to the group's experience in business and technology fields, and actively carried out the comprehensive cooperation with domestic and foreign customers with the establishment of EDA Laboratory at many universities. Empyrean takes "professionalism, dedication, collaboration and innovation" as its core value, and is ready to work with customers and partners for the common development and win-win cooperation.
Akeso Biopharma
Series B in 2017
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
Youon Bike
Series A in 2017
The company's original intention is to become the leading international green transport system suppliers and operators, through their IoT technology and large data platform, Youon provides a comprehensive and three-dimensional green transport service for partnered cities. Youon also acts as a stimulus in promoting the whole society to develop a "green travel, low-carbon environmental protection," mentality and living habit for the city in different regions in China. Youon has successfully in more than 200 counties across the country to promote public bicycle projects, the cumulative construction of 30,000 public bicycle site, 700,000 public bicycles and system equipment to provide technical support and services. Now the Youon national public bicycle system has over 15 million active users, the highest number of rent & return per day was recorded at 2.2 million times. In order to better serve the general public, Youon has set up 105 branches and operations centers nationwide, and 4,500 Youon Employees are dedicated to providing green and convenient service to the public. Youon now focuses on technological innovation and service innovation, their platform "Internet +" Yongan public bicycle system, support Alipay, micro letter, APP three ways of QR Code scan for bike rental.
Makeblock
Series B in 2017
Makeblock provides a do-it-yourself (DIY) robotics construction and programming learning platform designed to develop modular and programmable starter drone. Its DIY robotics construction and programming learning platform offer mechanical parts, multiple electronic modules and graphical programming software, enabling STEM learners, educators and hobbyists to construct robots that can be turned into a hovercraft, car and more. Jasen Wang founded Makeblock in 2013. Its headquarters is in Shenzhen in China.
Frontier Biotechnologies
Series C in 2017
Founded in 2013, Frontier Biotechnologies is a commercial-stage biopharmaceutical company headquartered in China with global vision and world-class competitiveness. Frontier Biotech is committed to discovering, development, manufacturing, and commercialization of innovative medicines that improve patient health. Their medicines typically address the unmet medical needs of patients in the areas of anti-HIV treatment and pain management. Frontier Biotech's first commercial product was approved by the National Medical Product Administration (NMPA), which is the counterpart of the Food and Drug Administration (FDA) in China, in May 2018 through a priority review process and has gained accelerated approval. Two additional drug candidates are currently undergoing multiple clinical trials in Phase I and Phase II in both China and the United States. Frontier Biotech brings together many of the best scholars, scientists, and professionals in R&D, senior management, marketing, international business development, and manufacturing. At Frontier Biotech, their long-standing commitment to excellence is in everything they do throughthe entire development cycle from drug discovery, preclinical research to global clinical development. This approach has enabled Frontier Biotech to emerge in the global market as a competitive player in the field of HIV long-acting treatment and immunotherapy.
ASR Microelectronics
Series A in 2017
ASR Microelectronics (Shanghai) Co., Ltd. specializes in the research, development, and manufacturing of semiconductors for mobile intelligent communication terminals and consumer electronics. Founded in 2015 and headquartered in Shanghai Zhangjiang Hi-Tech Park, the company produces a range of products including smartphones, modems, and integrated system-on-chip (SoC) solutions. ASR's offerings support various communication standards, including 2G, 3G, and 4G technologies, and encompass applications in the Internet of Things and navigation systems. The company has established a dedicated research and development team in both the United States and South Korea, focusing on platform development and technical support. In 2017, ASR expanded its capabilities through the acquisition of Marvell's Mobile Business Unit, enhancing its position in the market as a leading baseband provider in China. Major investors include several venture capital firms, highlighting ASR's strong financial backing and commitment to technological innovation in wireless communication chips.
Wangyudashi
Series A in 2016
Wangyudashi, which operates wangyuhudong.com, is a specialized platform for internet cafe payment and eSports registry developed by Zhejiang Wangjing Network Technology Co., Ltd. The company claims that the platform has already covered 30,000 Internet cafes in China with over ten million users and daily events of over 30.
DataEye
Series B in 2016
DataEye is a data solutions provider based in Shenzhen, China, specializing in the mobile gaming industry. Founded in 2013, the company offers a digital content marketing platform that includes a range of services such as marketing SaaS tools, strategy research consulting, and creative advertising planning. DataEye supports clients in the gaming and e-commerce sectors by delivering insights into consumer preferences through advanced data retrieval technologies. Its platform enables clients to track data from game operations and player actions, helping them to make informed decisions regarding product development, market strategies, customer support, and brand promotion. By leveraging its expertise, DataEye aims to enhance clients' sales growth and overall marketing effectiveness.
Youmi
Post in 2016
Youmi Media is an advertising company founded in 2010 and based in Guangzhou, China. It operates as an intelligent mobile advertising platform, acting as a connector between advertisers and publishers in the mobile app and new-media markets. Youmi offers a range of services, including performance-based advertising, app store optimization, and social media marketing, which are established in both domestic and international markets. The company features several notable products, such as ASOGrow, an automatic app store optimization platform, JadiDuit, which is recognized as Google's first offer wall, and in-house content media solutions. Youmi's mission is to help advertisers engage users effectively while supporting app developers, media buyers, affiliates, and ad networks in maximizing their revenue potential.
Transwarp
Series B in 2016
Transwarp develops big data software technologies for enterprises. The company's cloud-based platform offers an integrated, one-stop data processing and cloud operating system to explore the applications of big data infrastructure in enterprises, enabling enterprises to store, manage and analyze data.
Guanmai Technology
Series B in 2016
Guanmai Technology is currently the leading SaaS company in the B2B field of fresh food in China. Guanmai, formerly a fresh delivery company for small farmers and girls , has served nearly 30,000 restaurant companies in Guangdong. In 2014-16, it has deeply practiced the B2B business of food distribution, and has accumulated rich experience and industry knowledge of B2B food distribution.
Afanti
Series B in 2015
Afanti is an IT company engaged in the production and development of network and gaming products. It also offers a study mobile application that provides real-time answers and assistance to primary and middle school students. Afanti was founded in 2000 and is based in Beijing, China.
GENESKY
Series A in 2015
Genesky Technology (Suzhou) Co., Ltd. is a private company based in China, established in 2008, that specializes in the development and application of gene analysis technology. The company focuses on enhancing medical diagnostic accuracy through its genetic analysis services. It develops molecular diagnostic reagents and medical tests aimed at disease examination and provides hospitals with genetic testing services. By doing so, Genesky enables healthcare providers to improve diagnostic precision and make informed decisions regarding disease treatment.
iPinYou
Series C in 2015
Since its establishment in 2008, iPinYou has set its sights on being China's leading AI business solution platform through its cutting-edge big data and artificial intelligence technologies. Digital marketing solutions present the biggest opportunity, and the market is enormous. Having the top big data analysis and machine learning algorithm R&D team in China, iPinYou was the first to introduce big data research methodologies into the field of advertising technology. The company provides a world class real-time bidding architecture and algorithm, along with advanced audience analysis patents (DAAT). Through strategic collaborations with third-party data providers including telecommunication carriers, iPinYou has given its platform an advantageous position in China's fast moving internet industry. The company is working with increasingly more clients from Asia, Europe, and North America, offering a one-stop marketing intelligence platform.
Akeso Biopharma
Series A in 2015
Akeso Biopharma, based in Zhongshan, China, operates as a contract research organization (CRO) specializing in the discovery and development of antibody and protein drugs. Founded in 2012, the company provides comprehensive CRO services to both domestic and international pharmaceutical clients, focusing on areas such as protein expression, antibody generation, assay development, and humanization. Akeso has developed an extensive biopharmaceutical research and development platform, with a robust product pipeline that includes over 30 drugs targeting cancers, autoimmune diseases, inflammation, and cardiovascular conditions. Among these, 17 drugs have progressed to clinical stages, including two first-in-class bi-specific antibody drugs. The company collaborates with various pharmaceutical firms to innovate and develop new drug candidates, establishing itself as a leader in the industry through its advanced facilities and expertise.
Royole
Series C in 2015
Royole Corporation is a global leader in the development and manufacturing of advanced flexible displays, flexible sensors, and innovative smart devices. The company specializes in foldable smartphones and tablets, smart writing pads, wearables, and mobile theaters, offering products such as the FlexPai smartphone, RoWrite smart writing pad, and Moon mobile theater. Headquartered in Fremont, California, with an additional office in Shenzhen, China, Royole provides tailored solutions across various industries, including consumer electronics, automotive, computing, and telecommunications. Its display technology ranges from small panels for handheld devices to large high-resolution screens. The company also engages in consulting services and has established a strategic partnership with JD.COM to enhance its market reach through online sales. Founded in 2012, Royole continues to push the boundaries of flexible electronics to meet the evolving needs of consumers and businesses alike.
Shenzhen United Financial Services Group Co.,Ltd
Funding Round in 2015
Shenzhen United Financial Services Group Co., Ltd is a company that specializes in providing information technology outsourcing solutions specifically tailored for the financial services industry. Established in 2009, it is headquartered in the Futian District of Shenzhen, China. The company operates within the domestic financial service outsourcing sector, delivering services that enhance operational efficiency and support the technological needs of financial institutions.
Sunmi
Series B in 2015
Shanghai Sunmi Technology Co., Ltd is a technology-driven company that specializes in intelligent commercial hardware solutions for the online-to-offline (O2O) market. The firm develops smart point-of-sale devices, including handheld and desktop payment terminals, which operate on their proprietary Android-based payment system. These devices are designed to enhance the transaction process for businesses, offering a secure and efficient means for clients to digitize their operations. Sunmi aims to support O2O platforms and software developers by providing high-quality, cost-effective hardware that meets the demands of the mobile internet age. With a focus on integrating supply chains and collaborating with internet resources, Sunmi aspires to deliver significant value to its partners and contribute to the evolution of commercial practices. The company has attracted substantial investment from notable tech firms, underscoring its position in the commercial application sector.
Genrui Biotech
Angel Round in 2015
Genrui Biotech Inc. (formerly known as “Shenzhen Genius Electronics Co., Ltd”), is one of the leading Chinese companies specialized in developing, manufacturing and marketing IVD equipment and reagents. Established in 2004, Genrui has experienced great progress in both product development and market presence. Product range covers Immunoassay, Chemistry, Hematology, Urinalysis, and Point-of-Care, as well as associated reagents, while market presence spreads across whole of China and more than 100 countries worldwide.
Genrui Biotech
Series A in 2014
Genrui Biotech Inc. (formerly known as “Shenzhen Genius Electronics Co., Ltd”), is one of the leading Chinese companies specialized in developing, manufacturing and marketing IVD equipment and reagents. Established in 2004, Genrui has experienced great progress in both product development and market presence. Product range covers Immunoassay, Chemistry, Hematology, Urinalysis, and Point-of-Care, as well as associated reagents, while market presence spreads across whole of China and more than 100 countries worldwide.
Bangyan
Angel Round in 2014
Bangyan is a machinery manufacturing company that specializes in the production of military information and communication devices. The company offers engineering services, design and manufacture services, and aftersales services for their products. Their product portfolio includes communication computing platforms, converged communications, telecommunication, and information security devices.
Sunmi
Series A in 2014
Shanghai Sunmi Technology Co., Ltd is a technology-driven company that specializes in intelligent commercial hardware solutions for the online-to-offline (O2O) market. The firm develops smart point-of-sale devices, including handheld and desktop payment terminals, which operate on their proprietary Android-based payment system. These devices are designed to enhance the transaction process for businesses, offering a secure and efficient means for clients to digitize their operations. Sunmi aims to support O2O platforms and software developers by providing high-quality, cost-effective hardware that meets the demands of the mobile internet age. With a focus on integrating supply chains and collaborating with internet resources, Sunmi aspires to deliver significant value to its partners and contribute to the evolution of commercial practices. The company has attracted substantial investment from notable tech firms, underscoring its position in the commercial application sector.
TASS
Series A in 2014
TASS (北京江南天安科技) is a Chinese message safety services provider. It provides safety system building, safety solution, domestic password products, PKI/CA application security, financial IC card application security, security product integration, and other services for enterprises. The company is focused on the development of information security, providing consultation, assessment, and formulation of management rules and standards of information security for users. It provides services for the finance, government, energy, electricity, and enterprise industries. TASS was appointed as a designated service provider of information networks security guard in 2008 Olympic Games and Paralympic Games. It has established branches in Guangzhou, Shandong, Henan, and Shanghai. The company is headquartered in Beijing, China.
ShareSDK
Series A in 2013
ShareSDK (ShareSDK掌淘网络) is a mobile-based developer service platform providing socialized functions for APP. It is developed by Guangzhou ShareSDK Network Technology Co., Ltd., supporting more than 40 mainstream social platforms both at home and abroad. It helps developers easily access socialized sharing, registration, attention, and acquire users' information, friends’ lists and other mainstream socialized functions. With powerful statistical analysis management background, users, information flow, reflux ratio, transmission efficiency and other data can be known in real time, which effectively guides daily operation and promotion of mobile APP and brings in more socialized flow for APP. ShareSDK is offering service for 37,579 APPs, and it has become China's largest developer service platform.
evecom
Angel Round in 2013
Evecom Technology Co., Ltd. is an IT services provider based in Fuzhou, China, specializing in software research and development, solution integration, and operational maintenance. The company focuses on various sectors, including financial services, government, and enterprise customers, and is committed to advancing smart city initiatives through its offerings. Evecom delivers integrated information technology solutions that encompass transportation management, emergency response, water conservancy, and weather services, among others. By leveraging its expertise in cloud services and comprehensive technology platforms, the company aims to enhance the digital transformation efficiency of urban environments and support societal progress through technology.
Guo Xian Scientific and Technical Corporation
Series A in 2013
Guo Xian Scientific and Technical Corporation (深圳国显科技) is a Chinese high-tech company that integrates research, manufacturing, and sales. The company has invested in the research and development of TFT-LCM liquid crystal molds focusing on consumption products and industrial automatic products. Currently, it has launched applicable molds ranging from 3.5 inches to 11.6 inches. The company’s products are mainly applied to car, mobile TV, PMP, DVD, EPC, security and protection, and industrial control products. Guo Xian Scientific and Technical Corporation was founded in 2006.
E-Buy
Series A in 2013
E-Buy (China) Business Consulting Co., Ltd is a Chinese company specializing in VIP services and electronic transaction solutions. Established in 2005, E-Buy operates as an independent e-service terminal and information platform, offering B2B and B2C electronic exchange and authentication services. Its applications include electronic exchange certificates, third-party points redemption, e-coupons, and e-logistics, catering to major sectors such as finance, airlines, and telecommunications. The company has formed strategic partnerships with prominent financial institutions, including HSBC, Citibank, and Standard Chartered, as well as large conglomerates like HNA Group and Ping An Group. E-Buy is recognized for its consumer loyalty and credit redemption solutions, combining e-POS hardware with an advanced information technology platform to enhance customer loyalty programs and optimize transaction management for its clients. It is notable for being the only self-developed professional service enterprise in China to achieve financial certification.
LeEco
Series A in 2013
LeEco is a global internet company that offers video streaming services and technology devices. It is a fully domestically funded company. LeEco is a Chinese library of online movies, dramas and copyrighted sports videos. Founded in 2004, LeEco is formerly known as LeTV.
Blue Focus PR Consulting
Venture Round in 2013
Blue Focus PR Consulting is a Chinese professional organization providing public relations services. Blue Focus mainly provides professional public relations services including the spread of enterprise brands, generalization of products, crisis management, interacting marketing, activity management, the social responsibility of enterprises, and more. The company has won many awards and honors including the title of The Best Public Relations Company in Asia Pacific and greater China and ranked 29th in Global Public Relations Enterprises. The company’s core client base concentrates on three fields including IT, automobile, and consumer goods with companies such as Lenovo, Canon, Guangqi, Toyota Automobile, Baidu, and BMW. Blue Focus was founded in 1996.
Acetec Semiconductor
Series A in 2013
Zhenjiang Acetic Semiconductor Co., Ltd. is a Chinese company specializing in integrated circuit (IC) testing services. It develops IC testing solutions and programs, and conducts tests on wafers and chips for IC design firms, wafer manufacturers, and packaging and testing facilities. With an investment exceeding 300 million Yuan, the company has established a comprehensive business framework for middle- and high-end testing services. Its operations include an advanced research and development center in Beijing, a talent training institute, and a small-scale production base in Wuxi. Headquartered in Zhenjiang, China, Zhenjiang Acetic Semiconductor aims to support its clients in achieving their business objectives through tailored testing services and new product verification analysis.
Nanjing Shouwangxing IT
Venture Round in 2013
Nanjing Shouwangxing IT Co., Ltd. (守望星科技) is a Chinese company specialized in international software outsourcing and the development of internet hardware and software systems. The mobile internet (MI) department of the company covers all mobile terminal services and majors in Android mobile product development, IMS, VOIP, explorer, e-book, LBS, PIM, various mobile applications, App Store, App Market, OVI Store, Android digital frame, Android TV, and more. Shouwangxing IT primarily targets the Chinese, American, and European markets.
BGI Tech
Private Equity Round in 2012
BGI Tech Solutions Co., Ltd., founded in 2012 and headquartered in Shenzhen, China, is a leading provider of advanced life sciences technology and bioinformatics services. The company operates lab facilities in Hong Kong, Wuhan, and Sacramento, along with branch offices in various regions, including Europe, the Americas, and multiple cities in mainland China. BGI Tech's extensive service network spans over 100 countries and regions, collaborating with more than 10,000 organizations and 30,000 partners on a multitude of research projects, including significant international genome initiatives. The company specializes in a wide range of sequencing solutions, including genomics, transcriptomics, epigenomics, metagenomics, PDXomics, and single-cell sequencing, among others. Through its commitment to integrated omics platforms, BGI Tech aims to accelerate advancements in life sciences and address critical health, agricultural, energy, and environmental challenges, ultimately contributing to the betterment of society.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.